Macquarie Group LTD Cumberland Pharmaceuticals Inc Transaction History

Macquarie Group LTD

  • $90.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019
SELL
$5.06 - $6.5 $10,595 - $13,611
-2,094 Closed
0 $0
Q4 2018

Feb 15, 2019
SELL
$5.31 - $7.0 $19,243 - $25,368
-3,624 Reduced 63.38%
2,094 $13,000
Q3 2018

Nov 15, 2018
BUY
$5.5 - $6.3 $8,899 - $10,193
1,618 Added 39.46%
5,718 $33,000
Q2 2018

Aug 14, 2018
BUY
$5.91 - $6.9 $24,231 - $28,290
4,100 New
4,100 $25,000

Others Institutions Holding CPIX

# of Institutions
23
Shares Held
1.97M
Call Options Held
44.2K
Put Options Held
0
View Full List

About CUMBERLAND PHARMACEUTICALS INC

CPIX Quotes by TradingView
  • Ticker CPIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 14,661,900
  • Market Cap $16M
  • Description
  • Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...
More about CPIX
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email